Health‐related quality of life in adult‐type ovarian granulosa cell tumor survivors
Acta Obstetricia et Gynecologica Scandinavica · 2025
DOI: 10.1111/aogs.15144 ↗At a glance
Journal article in Acta Obstetricia et Gynecologica Scandinavica, 2025. Written by Ulla-Maija Haltia and 4 co-authors. Institution: Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland. Major MEDLINE topics: Quality of Life, Granulosa Cell Tumor, Ovarian Neoplasms, Survivors. 39 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Helsingin ja Uudenmaan Sairaanhoitopiiri.
Abstract (original language)
Introduction
Adult‐type granulosa cell tumor (AGCT) is a rare, slow‐growing ovarian neoplasm with a tendency for late relapses. Surgery is the cornerstone of the treatment, and chemotherapy and hormonal treatment are administered in advanced and recurrent disease. The objective of our study was to assess health‐related quality of life (HRQoL) in AGCT survivors. Material and Methods 15D and European Organization for Research and Treatment of Cancer (EORTC‐QLQ‐C30) questionnaires were collected from our prospective AGCT patient cohort, consisting of 171 AGCT survivors. The age‐standardized general female population was used as a reference for 15D comparison. Clinical and sociodemographic variables and EORTC‐QLQ‐C30 symptom and function scales were used as independent variables in regression analysis explaining the variance in the 15D score.
Results
Eighty‐six women (50.3%), with a mean age of 68 years, returned the questionnaires. The HRQoL of AGCT survivors was similar to the general female population. The mean 15D score in our patient group was 0.891 (reference population score 0.899, p = 0.454). The scores were slightly lower on the 15D dimensions of excretion and sexual activity, whereas mental function scores were higher compared with the reference population. A history of tumor recurrence, an increasing number of other chronic illnesses, and financial difficulties each diminished HRQoL in our patient cohort. Regressing the EORTC variables on 15D produced a high explanatory power and accurate predictions of 15D scores.
Conclusions
HRQoL of AGCT survivors was equal to that of the controls. Mapping EORTC‐QLQ‐C30 to 15D validly predicted 15D scores in AGCT survivors, confirming the usefulness of generic 15D for estimating quality‐adjusted life years in cancer patient trials.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
- MedEngine Oy, Helsinki, Finland.
- Department of Public Health, University of Helsinki, Helsinki, Finland.
ORCID profiles: Ulla-Maija Haltia
Funding
- Helsingin ja Uudenmaan Sairaanhoitopiiri
Cite
APA
Haltia, U. M., Torvinen, S., Bryk, S., Sintonen, H., & Tapper, J. (2025). Health‐related quality of life in adult‐type ovarian granulosa cell tumor survivors. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.15144
Vancouver
Haltia UM, Torvinen S, Bryk S, Sintonen H, Tapper J. Health‐related quality of life in adult‐type ovarian granulosa cell tumor survivors. Acta Obstetricia et Gynecologica Scandinavica. 2025. doi:10.1111/aogs.15144
BibTeX
@article{Haltia2025,
author = {Haltia, Ulla-Maija and Torvinen, Saku and Bryk, Saara and Sintonen, Harri and Tapper, Johanna},
title = {Health‐related quality of life in adult‐type ovarian granulosa cell tumor survivors},
journal = {Acta Obstetricia et Gynecologica Scandinavica},
year = {2025},
doi = {10.1111/aogs.15144}
}
EUVIMED